Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

A Boston biotech startup announced a major step towards reversing age-related vision loss. Their experimental gene therapy, ...

A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.

Weight loss drugs show signs of slowing biological aging, scientists discover - GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

The government regards human aging not simply as a natural phenomenon but as a treatable disease, and has officially launched ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...